Rokos Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,474,348
| Closed | -$3.94M | – | 97 |
|
|
2023
Q3 | $3.94M | Hold |
6,474,348
| – | – | 0.03% | 63 |
|
|
2023
Q2 | $8.06M | Hold |
6,474,348
| – | – | 0.08% | 45 |
|
|
2023
Q1 | $11.4M | Buy |
6,474,348
+3,448,138
| +114% | +$6.07M | 0.84% | 22 |
|
|
2022
Q4 | $9.15M | Hold |
3,026,210
| – | – | 0.4% | 19 |
|
|
2022
Q3 | $15.4M | Hold |
3,026,210
| – | – | 0.46% | 26 |
|
|
2022
Q2 | $12.5M | Buy |
3,026,210
+2,048,547
| +210% | +$8.44M | 0.37% | 32 |
|
|
2022
Q1 | $5.86M | Buy |
977,663
+437,803
| +81% | +$2.62M | 0.27% | 34 |
|
|
2021
Q4 | $4.11M | Hold |
539,860
| – | – | 0.25% | 21 |
|
|
2021
Q3 | $4.95M | Buy |
+539,860
| New | +$4.95M | 0.11% | 24 |
|